Introduction: Urinary Tract Infections (UTIs) are common diseases and are treated by
antibiotics, and over the years, multiple drug resistance from gram-negative bacteria has …

Objective This study assessed the characteristics of pathogens identified in clinical isolates
from patients with urinary tract infection (UTI) and their in vitro sensitivity to commonly used …

Aim: Urinary tract infections (UTIs) caused in particular by extended-spectrum beta-
lactamase (ESBL)-producing Escherichia coli strains are related with high morbidity and …

Background: Urinary tract infection due to Escherichia coli is one of the common problem in
clinical practice. Various drug resistance mechanisms are making the bacteria resistant to …

Background: Urinary tract infections (UTI) considered, as the most frequently diagnosed
infections constitute Escherichia coli (E. coli) as the most common etiological agents isolated …

Materials and Methods: The study was performed during a 6 month period (February 2014 to
August 2015). A total of 219 non-duplicate urinary isolates of Enterobacteriaceae were …

Objectives Escherichia coli (E. coli)-induced urinary tract infection (UTI) is a common
infection associated with frequent use of antibiotics and the increase in global antibiotic …

Purpose The appearance of extended-spectrum beta-lactamase (ESBL)-producing gram-
negative bacteria in urinary tract infection (UTI) constitutes an important therapeutic …

Purpose The aim of this study was to determine the prevalence and risk factors for
community-acquired urinary tract infections (CA-UTIs) caused by extended-spectrum β …

Objective: To determine the in vitro activity of Fosfomycin tromethamine against extended
spectrum beta-lactamase producing uropathogens. Study Design: Experimental study. Place …